Get weekly updates on this stock
CN The YouTuber identifies Centene as the cheapest stock in the healthcare insurance sector based on his 'value ratio' formula, noting its price is the…
The YouTuber recommends healthcare insurance companies, specifically Centene, as being very cheap and undervalued. He suggests them as a good opportunity for those with patience, having previously bought Oscar Health for a quicker bounce but now seeing Centene as a better current value.
The YouTuber recommends healthcare insurance companies, specifically Centene, as being very cheap and undervalued. He suggests them as a good opportunity for those with patience, having previously bought Oscar Health for a quicker bounce but now seeing Centene as a better current value.
“Instead, Saint Centine and Molina are still very, very cheap in my opinion, very undervalued.”
The YouTuber is considering adding Centene to his portfolio, believing the entire healthcare insurance sector is undervalued. He notes that Centene trades at a lower forward P/E ratio (13) compared to UnitedHealth (18), which was recently bought by Berkshire Hathaway, suggesting it offers a better value proposition within the sector.
“I'm considering adding some centine or molina.”
The YouTuber identifies Centene as the cheapest stock in the healthcare insurance sector based on his 'value ratio' formula, noting its price is the same as 10 years ago while revenues have grown 800% and its price-to-sales ratio is under 0.1. He believes it is wrongly priced and could reach $100 if fully valued, making it a strong long-term investment.
“But just looking at the formula and the pure numbers, the cheapest is sentin CNC. It's trading at $28. The same price it was 10 years ago. while its revenues has grown 800%. As a price to sell ratio under 0.1 is just crazy cheap.”
The YouTuber advises against Centene, despite its low P/E ratio, due to razor-thin profit margins in the healthcare insurance industry. He notes that increased utilization of insurance post-pandemic, clawed-back subsidies, and slow government reimbursements are severely impacting profitability.
The YouTuber advises against Centene, despite its low P/E ratio, due to razor-thin profit margins in the healthcare insurance industry. He notes that increased utilization of insurance post-pandemic, clawed-back subsidies, and slow government reimbursements are severely impacting profitability.
“Centine books a profit margin of just $1.3% for every $100 in revenue. It converts just $1 of that into profits. That doesn't leave a whole lot of room for error.”
The YouTuber suggests CNC as a strong pick based on its valuation, despite having a smaller Medicare Advantage market share. He highlights its low P/E (10x) and price-to-sales (0.19x) ratios, and recent upgrades to its provider tools, making it a good value play even if it benefits less from the Medicare Advantage bump.
“Valuation is even lower here at just 10 times PE and that same. one n times price to sales but not the same debt danger so this one is a good value play even though it won't benefit much from that Advantage plan.”
A named stock, a clear buy or sell stance, and real reasoning. Passing mentions and hype are filtered out.
Each channel counts once per stock, so a single loud voice can't skew the ranking.
We weigh how many creators agree, how convinced they are, and how recent each call is.
2 finance YouTubers analysed Centine with qualified reasoning — consensus: Hold, average analysis quality 73/100. This is not financial advice; review the individual analyses and sources above.
Among the channels covering Centine, 1 are buying and 1 are selling or avoiding — overall Hold.
The price targets mentioned for Centine range 100. Targets are the YouTubers' own; not a guarantee.
Only qualified analyses count: a clear buy/sell stance on Centine with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.